Abstract
A multicentre Phase II clinical trial was recently undertaken to document the value of treatment with recombinant human granulocyte colony-stimulating factor (rG-CSF) in children with congenital agranulocytosis. To assess the impact of such therapy on health-related quality of life (HRQOL), we developed a questinonnaire that was administered to the parents of study patients, twice prior to the initiation of treatment, and then monthly thereafter for six months. The questionnaire focused on several aspects of HRQOL that we thought were important in this patient population, including functional status, general health perceptions, activity limitation, disease symptoms, and discomfort associated with therapy. In this paper, we describe the questionnaire that we developed and the process by which it was translated into several languages. We also report on the impact of rG-CSF therapy on HRQOL. A total of 130 questionnaires were administered to the parents of 19 study patients between the ages of four and one-half months and 18 years in 11 study centres in four countries. Although our sample size is small, our findings suggest that treatment with rG-CSF may result in significant improvements in general health perceptions, limitations of daily activities, and symptoms of the disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dale DC. Neutrophil disorders. Benign, quantitative abnormalities of neutrophils. In: Williams WJ, Beutler E, Ersley AJ, Lichtman MA, eds. Hematology (ed 4). New York, NY: McGraw-Hill, 1990: 807.
Weetman RM, Boxer LA. Childhood neutropenia. Ped Clin N Am 1980; 27: 361.
Bonilla MA et al. Effect of recombinant granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. New Engl J Med 1989; 320: 1574–80.
Dale DC, Bonilla MA, Davis MW et al. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 1993; 81: 2496–502.
Lewis CC, Pantell RH, Kieckhefer GM. Assessment of children's health status: field test of new approaches. Med Care 1989; 27: S54–65.
Stein REK, Jessop DJ. A noncategorical approach to chronic childhood illness. Public Health Rep 1982; 97: 354–62.
Stein REK, Jessop DJ. Functional status II(R): a measure of child health status. Med Care 1990; 28: 1041–55.
Eisen M, Donald CA, Ware JEJr. et al. Conceptualization and Measurement of Health for Children in the Health Insurance Study. R-2313-HEW. Santa Monica, CA: The RAND Corporation, 1980.
National Center for Health Statistics. National Health Interview Survey, 1986: Interviewer's Manual, HIS-100. Hyattsville, Maryland: National Center for Health Statistics, 1987.
Flaherty JA, Gaviria M, Pathak D et al. Developing instruments for cross-cultural psychiatric research. J Nerv Mental Dis 1988; 176: 257–63.
Gilson BS, Erickson D, Chavez CT et al. A Chicano version of the sickness impact profile (SIP). Culture, Medicine, Psychiatry 1980; 4: 137–50.
Stein REK, Jessop DJ. Measuring health variables among Hispanic and non-Hispanic children with chronic conditions. Public Health Rep 1989; 4: 377–84.
Hunt SM, Alonso J, Bucquet D et al. Cross-cultural adaptation of health measures. Health Policy 1991; 19: 33–44.
Hunt SM. Cross-cultural comparability of quality of life measures. Drug Info J 1993; 27: 395–400.
Hendricson WD, Russell IJ, Prhihoda TJ et al. An approach to developing a valid Spanish language translation of a health-status questionnaire. Med Care 1989; 27(10): 959.
Alonso J, Anto JM, Moreno C. Spanish version of the Nottingham Health Profile: translation and preliminary validity. Am J Public Health 1990; 80(6): 704.
Phillips HP. Problems of translation and meaning in field work. Human Organiz 1959; 18: 184–92.
Nunnally JC. Psychometric Theory. New York: McGraw-Hill, 1978.
Snedecor GW, Cochron WG, eds. Statistical Methods. (eighth edition) Ames: Iowa State University Press, 1989.
Dixon WJ, Brown MB, Engelman L, Frane JW, Hill MA, Jennrich RI et al., eds. BMDP Statistical Software Manual. Berkley: University of California Press, 1985.
Fazio MT, Glaspy JA. The impact of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia. Oncol Nursing Forum 1991; 18: 1411–14.
Jones EA, Bolyard AA, Dale DC. Quality of life with severe chronic neutropenia receiving long-term treatment with granulocyte colony-stimulating factor. J Am Med Assoc 1993; 270: 1132–3.
Cadman D, Goldsmith C, Bashim P. Values, preferences, and decisions in the care of children with developmental disabilities. J Devel Behav Pediat 1984; 5: 60–4.
McCormick MC, Athreya BH, Bernbaum JC et al. Preliminary observations on maternal rating of health of children: data from these subspecialty clinics. J Clin Epidemiol 1988; 4: 323–9.
Pantell RH, Lewis CC. Measuring the impact of medical care on children. J Chron Dis 1987; 40: 99S-108S.
Weissman MM, Orvaschel H, Padian N. Children's symptom and social functioning self-report scales. J Nerv Mental Dis 1980; 168: 736–40.
Author information
Authors and Affiliations
Additional information
This study was supported with funding from Chugai Rhône-Poulenc. At the time the study was conducted, Drs Cleary and Oster and Ms. Morrissey were consultants to the company.
Rights and permissions
About this article
Cite this article
Cleary, P.D., Morrissey, G., Yver, A. et al. The effects of rG-CSF on health-related quality of life in children with congenital agranulocytosis. Qual Life Res 3, 307–315 (1994). https://doi.org/10.1007/BF00451722
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00451722